Key Insights Significantly high institutional ownership implies GSK's stock price is sensitive to their trading ...

Harvey Jones has something to celebrate after a positive set of results boosted the GSK share price after a disappointing run ...

Mark Hartley weighs up the growing potential in GSK as its share price makes rare gains following a promising set of results.

Harvey Jones has something to celebrate after a positive set of results boosted the GSK share price after a disappointing run. Is there scope for more growth? The content of this article is ...

Mark Hartley weighs up the growing potential in GSK as its share price makes rare gains following a promising set of results. When investing, your capital is at risk. The value of your ...

The stock market extended its winning streak on Wednesday, closing firmer as investors seemed to have already priced in the ...

16p per share). Dividends remain an essential component of total shareholder return and GSK recognises the importance of dividends to shareholders. On 23 June 2021, at the GSK Investor Update ...

The user of the website is referred to as "you" and "your". By posting on our share chat boards you are agreeing to the following: If you are going to post non-English, please also post an English ...

The pharmaceutical company said promising pipeline developments and high demand for drugs in its specialty segment lifted ...

Even as GSK’s RSV vaccine launch hits a serious slowdown, the British pharma has dialed up its long-term sales guidance once ...

An improved long-term sales target today revitalised GSK shares after their dismal 2024. The confidence in GSK’s drugs ...

While vaccine sales dropped, GSK raised its revenue guidance for 2031 with speciality medicines expected to drive that growth ...